Intrepid Labs

Intrepid Labs operates an AI-enabled formulation development platform designed to accelerate drug development timelines and improve therapeutic outcomes. The platform guides pharma partners through formulation optimization by combining artificial intelligence, advanced robotics, and deep pharmaceutical formulation expertise.

Core Offering:

• AI-guided formulation design workflows that explore the formulation design space and identify optimal development paths
• Input: candidate molecule and target product profile
• Output: optimized, manufacturable formulation ready for clinical advancement

Partnerships: Supports pharma partners ranging from emerging biotechs to leading global pharmaceutical companies. Multi-year licensing agreements with partners such as Quotient Sciences demonstrate commitment to sustained collaboration.

Differentiation: The platform is purpose-built for pharmaceutical development, leveraging agentic AI to identify more target-product-profile-matched formulations within the same experimental budget, as demonstrated in peer-reviewed research.